These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3063168)

  • 21. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
    Zeng YB; Qian YS; Ma L; Gu HN
    Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
    Hiratani T; Yamaguchi H
    Jpn J Antibiot; 1994 Feb; 47(2):125-8. PubMed ID: 8151906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mode of action of clinically important antifungal drugs.
    Kerridge D
    Adv Microb Physiol; 1986; 27():1-72. PubMed ID: 3532715
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and structure-activity relationships of side-chain-substituted analogs of the allylamine antimycotic terbinafine lacking the central amino function.
    Nussbaumer P; Leitner I; Mraz K; Stütz A
    J Med Chem; 1995 May; 38(10):1831-6. PubMed ID: 7752208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of naphthalene-substituted derivatives of the allylamine antimycotic terbinafine.
    Nussbaumer P; Dorfstätter G; Leitner I; Mraz K; Vyplel H; Stütz A
    J Med Chem; 1993 Sep; 36(19):2810-6. PubMed ID: 8410994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of terbinafine with human serum and serum proteins.
    Ryder NS; Frank I
    J Med Vet Mycol; 1992; 30(6):451-60. PubMed ID: 1287164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terbinafine resistance in a pleiotropic yeast mutant is caused by a single point mutation in the ERG1 gene.
    Klobucníková V; Kohút P; Leber R; Fuchsbichler S; Schweighofer N; Turnowsky F; Hapala I
    Biochem Biophys Res Commun; 2003 Sep; 309(3):666-71. PubMed ID: 12963042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene.
    Ryder NS; Dupont MC; Frank I
    FEBS Lett; 1986 Aug; 204(2):239-42. PubMed ID: 3525224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
    Shadomy S; Espinel-Ingroff A; Gebhart RJ
    Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical characterization of terbinafine-resistant Trichophyton rubrum isolates.
    Favre B; Ghannoum MA; Ryder NS
    Med Mycol; 2004 Dec; 42(6):525-9. PubMed ID: 15682641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of naftifine, a new antifungal agent.
    Georgopoulos A; Petranyi G; Mieth H; Drews J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):386-9. PubMed ID: 7247366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antileishmanial activity of inhibitors of steroid biosynthesis and combinations of antileishmanial agents.
    Berman JD; Gallalee JV
    J Parasitol; 1987 Jun; 73(3):671-3. PubMed ID: 3037057
    [No Abstract]   [Full Text] [Related]  

  • 33. Biological, biochemical, and molecular characterization of a new clinical Trichophyton rubrum isolate resistant to terbinafine.
    Osborne CS; Leitner I; Hofbauer B; Fielding CA; Favre B; Ryder NS
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2234-6. PubMed ID: 16723593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of terbinafine on reactive oxygen species (ROS) generation by Candida albicans.
    Sander CS; Hipler UC; Wollina U; Elsner P
    Mycoses; 2002 Jun; 45(5-6):152-5. PubMed ID: 12100530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new era in antimycotic agents.
    Rippon JW
    Arch Dermatol; 1986 Apr; 122(4):399-402. PubMed ID: 3006601
    [No Abstract]   [Full Text] [Related]  

  • 37. Antidermatophytic activity of allylamine derivatives.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of terbinafine against serious fungal pathogens.
    Ryder NS
    Mycoses; 1999; 42 Suppl 2():115-9. PubMed ID: 10865917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A non-azole inhibitor of lanosterol 14 alpha-methyl demethylase in Candida albicans.
    Capobianco JO; Doran CC; Goldman RC; De B
    J Antimicrob Chemother; 1992 Dec; 30(6):781-90. PubMed ID: 1289352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and structure-activity relationships of benzo[b]thienylallylamine antimycotics.
    Nussbaumer P; Petranyi G; Stütz A
    J Med Chem; 1991 Jan; 34(1):65-73. PubMed ID: 1992153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.